Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Bayer (Italy)
h-index: 45
Total citations: 8,514
Total papers: 285
Homepage:
http://www.bayer.it/
Recent papers from Bayer (Italy)
Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial
European Urology · 2026
Efficacy and safety of larotrectinib in patients with non-primary central nervous system TRK fusion cancer: An updated analysis.
Journal of Clinical Oncology · 2026
Prostate-specific antigen outcomes of darolutamide and androgen deprivation therapy in patient subgroups by age, comorbidities, and concomitant medications: ARANOTE post hoc analyses.
Journal of Clinical Oncology · 2026
Efficacy and safety of larotrectinib in patients with TRK fusion lung cancer: An updated analysis.
Journal of Clinical Oncology · 2026
SOHO-01: Updated safety and efficacy of sevabertinib in patients with advanced HER2 -mutant non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology · 2026
NTRK Gene Fusions: A Compendium of Fusion Partners and Tumor Types
JCO Precision Oncology · 2026
Transportability of the comparative effect of finerenone for the treatment of symptomatic chronic heart failure with left ventricular ejection fraction of ≥40%: insights from the FINEARTS-HF trial
Journal of Comparative Effectiveness Research · 2026
Use of Aflibercept 8 mg for the Treatment of Diabetic Macular Edema in Italy: A Cost-Minimisation Analysis Based on an Indirect Treatment Comparison
Advances in Therapy · 2026
209P Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
ESMO rare cancers. · 2026
Efficacy and safety of darolutamide and ADT in patient subgroups by baseline comorbidities and concomitant medications: ARANOTE post hoc analyses.
Journal of Clinical Oncology · 2026
Analysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in patients with metastatic hormone-sensitive prostate cancer: From the ARASENS trial.
Journal of Clinical Oncology · 2026
Greenhouse Vertical Cultivation to Improve Production Earliness and Fruit Yield and Quality of Melon
Plants · 2026
Initiation, titration, and safety of vericiguat for treatment of heart failure in United States clinical practice
American Heart Journal Plus Cardiology Research and Practice · 2026
Effect of silage from a new brachytic corn hybrid with a high harvest index on feeding behavior and performance of lactating dairy cows
Journal of Dairy Science · 2025
Assessing yield and nutritive value of corn varieties for silage production carrying the brachytic2 mutation harvested at different stages of maturity
Journal of Dairy Science · 2025
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer
Cancer Discovery · 2025
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer
European Urology Oncology · 2025
Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials
Clinical Pharmacology & Therapeutics · 2025
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
ESMO Open · 2025